Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) General Information

Description

An asset of BN104 Menin Inhibitor based in Shanghai, China.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Shanghai
  • China
Primary Industry
Buildings and Property
Other Industries
Other Devices and Supplies
Acquirer
Corporate Office
  • Shanghai
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China)‘s full profile, request access.

Request a free trial

Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China)‘s full profile, request access.

Request a free trial

Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) FAQs

  • Where is Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) headquartered?

    Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) is headquartered in Shanghai, China.

  • What industry is Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) in?

    Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China)’s primary industry is Buildings and Property.

  • Is Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) a private or public company?

    Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) is a Private company.

  • What is Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China)’s current revenue?

    The current revenue for Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) is .

  • Who are Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China)’s investors?

    BioNova Pharma has invested in Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China).

  • When was Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) acquired?

    Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) was acquired on 23-May-2025.

  • Who acquired Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China)?

    Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) was acquired by Servier.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process